Advertisement

Topics

Companies Related to "Combination Chemotherapy in Treating Patients With Advanced Cancer" [Most Relevant Company Matches] RSS

17:17 EST 16th February 2019 | BioPortfolio

Here are the most relevant search results for "Combination Chemotherapy in Treating Patients With Advanced Cancer" found in our extensive corporate database of over 50,000 company records.

Showing "Combination Chemotherapy Treating Patients With Advanced Cancer" Companies 1–25 of 7,500+

Relevant

Cancer Therapeutics, Inc.TM

Founded in 1991, Cancer Therapeutics, Inc.TM (CTI) is a biotherapy company that is a leader in activated cell technology for cancer therapy. CTI's laboratory offers access to technologies grouped under the modality of Biotherapy. Biotherapy is based on treatments that enhance the patient's own immune system to attack the invading cancer. Research has shown cancer to be a highly individualized dise...


Genetronics Biomedical

Genetronics' most advanced effort involves treating those with head and neck cancer, a particularly devastating cancer that can severely limit the ability of these patients to see, taste, hear, talk, breathe, or swallow. Genetronics received approval from the U.S. Food and Drug Administration and initiated Phase II multi-center clinical trials at nine sites in the U.S. The trials test the effectiv...

Sonrgy, Inc.

Sonrgy is a preclinical stage biotechnology company based in San Diego, California that is developing a targeted chemotherapy delivery platform to improve survival and quality of life for millions of cancer patients. Sonrgy’s tiny nanocarriers safely transport potent chemotherapy drugs to cancer tumors and release high doses on command in response to a focus...


ProCertus BioPharm, Inc.

ProCertus BioPharm is an oncology-based pharmaceutical company whose primary mission is to protect cancer patients against the side effects of chemotherapy and radiotherapy.ProCertus has established proof of concept in animal models for its product candidates, DermX, ProDermaCel™, and OralX, proprietary pharmaceuticals designed to reduce or eliminate the side effects associated with cancer thera...

US Bioscience Incorporated

US Bioscience, Inc. is a pharmaceutical company focused on the development and commercialization of therapies for patients with cancer and allied diseases such as AIDS. Currently, three of the Company's products are marketed by US Bioscience and its commercial partners: Ethyol® (amifostine) A selective cytoprotective agent for reduction of toxicities associated with cancer chemotherapy. Hexalen...

Targeted Diagnostics and Therapeutics

TDT has emerged as a leader in the development of innovative molecular diagnostics and therapeutics that can improve the quality of life of patients with colorectal cancer and gastrointestinal malignancies. Focused on innovative research and cutting edge technology, TDT has developed highly specific tests to detect colorectal cancer cells in lymph nodes from patients who have undergone surgical st...

DiaTech Oncology

DiaTech Oncology is a privately held clinical pathology laboratory that offers patient-specific chemotherapy testing to help oncologists determine the best cancer treatment plans for their patients. DiaTech utilizes a patented technology called the Microculture Kinetic (MiCK) assay, which measures apoptosis (cell death) induced in a specific patient’s...

Odonate Therapeutics, Inc.

Odonate Therapeutics, Inc. is a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer. The Company’s initial focus is on the development of tesetaxel, a novel, orally administered chemotherapy agent belonging to the taxane class. Odonate’s goal for tesetaxel is to ...

Targeted Diagnostics & Therapeutics, Inc

TDT has emerged as a leader in the development of innovative molecular diagnostics and therapeutics that can improve the quality of life of patients with colorectal cancer and gastrointestinal malignancies. Focused on innovative research and cutting edge technology, TDT has developed highly specific tests to detect colorectal cancer cells in lymph nodes from patients who have undergone surgical st...

GammaCan

GammaCan is a biopharmaceutical company focused on clinical-phase development and commercialization. GammaCan’s initial therapy under development is a first-in-class anti-cancer immunotherapy aimed at preventing metastasis (the spread of cancer to other parts of the body) of a variety of cancers. GammaCan’s first product was entered to phase-II clinical trials.GammaCan’s innovative treatment...

KIYATEC, Inc.

KIYATEC is changing the future of cancer care by accurately predicting patient-specific response and non-response to chemotherapy drugs before treatment begins. Wasted time is the enemy of cancer patients and there is currently no way to accurately predict which cancer patients will respond to standard oncology treatments. KIYATEC has developed a validated...

Replicon Technologies Incorporated

Replicon Technologies, Inc. (RTI) is an emerging biotechnology company focused on the use of replicons, non-replicating RNA viral particles, for the treatment of patients with cancer. RTI is founded on research and development performed at the University of Alabama at Birmingham (UAB), and supported by competitive grants from the National Institutes of Health, the Department of Defense, and SBIR ...

Oncology Hematology Group of South Florida

We truly care about our patients. Our compassionate doctors rely on the latest treatments and advanced technologies-many of which are available at OHGSF long before other medical practices. Constantly seeking ways to improve results, our physicians always put the patient first anr never sacrifice quality of care. We handle every aspect of a patient's treatment from chemotherapy and radiation to th...

Cancer Supportive Care Programs

The mission of the Cancer Supportive Care Web Site (CSCW) is to provide multidisciplinary information and services for cancer patients and their families/friends This website provides online support for patients undergoing surgery, radiation therapy, chemotherapy, hormonal therapy or immunotherapy. El Cuidado Sustento Del Cáncer de Ernest H. Rosenbaum, MD y Isadora R. Rosenbaum, MA La Declaració...

Tennessee Cancer Patient Coalition

The Tennessee Cancer Patient Coalition’s mission is to serve as an advocate for cancer patients and their caregivers. The Coalition believes cancer patients should have the opportunity to make informed decisions about their care and have equal access to the most advanced treatment methods available. Proton Therapy is the most advanced form of radiatio...

Cancer Vaccines Ltd

Cancer Vaccines Ltd is a biopharmaceutical company focused on the development and commercialisation of safe and effective therapeutic vaccines for the treatment of cancer. The company was founded in 1999 and won a DTI SMART Award.The attraction of a vaccination based approach to treating cancer is widely acknowledged, and many researchers and clinicians have worked in this area. Historically the a...

Intensity Therapeutics, Inc.

Intensity Therapeutics, Inc. is a specialty pharmaceutical company whose mission is to greatly extend the lives of patients with solid tumor cancers. Intensity Therapeutics is pioneering a new approach to treat cancer referred to as in situ chemovaccination. The Company creates novel, proprietary formulations of proven chemotherapy drugs. These products, w...

Glactone Pharma AB

Glactone Pharma AB is developing a drug for the treatment of castration resistant prostate cancer. Research has shown that the natural product galiellalactone can modulate a signaling protein (STAT3) that is over activated in cancer cells. The goal is to develop drugs against metastasizing cancer where galiellalactone is used as a chemical starting point to make new novel, patentable compounds. ...

Generon (Shanghai) Corporation Ltd.

Generon (Shanghai) Corporation Ltd. is a biotechnology company based in China with a mission to develop innovative biological therapies for patients in China and around the world. F-627 is a newer generation recombinant human granulocyte colony-stimulating factor (G-CSF) that helps the cancer patients to recover from chemotherapy induced neutropenia, a pot...

Serenex

Serenex is an integrated oncology-focused drug discovery and development company. Our mission is to improve the lives of cancer patients by developing proprietary therapeutic and supportive care products. Our most advanced program, SNX-1012, is a product for chemotherapy and radiation-induced oral mucositis. This is scheduled to complete Phase 2 trials in Q1 2007. Our most advanced preclinical-sta...

Lake Champlain Gynecologic Oncology , P.C.

Lake Champlain Gynecologic Oncology is a comprehensive gynecologic oncology center dedicated to the care of women with or suspected of having gynecologic cancers as well as regular gynecologic care for cancer survivors and healthy women. Our office comprises 5500 square feet of easily accessible space with ample on-site parking, 6 exam rooms, a laboratory, a pharmacy, and a chemotherapy infusion c...

Brooklyn ImmunoTherapeutics LLC

Brooklyn ImmunoTherapeutics (formerly IRX Therapeutics) is focused on exploring the role that cytokine-based therapy can have in treating patients with cancer, both as a single agent and in combination with other anti-cancer therapies.

Mountain Blue Cancer Care Center

Founded by Medical Director Dr. Samir Witta, Mountain Blue Cancer Care Center is a private oncology practice that delivers personalized cancer treatment through advanced genomic testing. With doctorates in both Genetics and Medicine, Dr. Witta is one of the region’s leading pioneers in developing tumor-specific treatments based on genomic testing, whi...

Aranesp

Aranesp® (darbepoetin alfa) is indicated for the treatment of anemia associated with chronic renal failure (CRF), including patients on dialysis and patients not on dialysis, and for the treatment of anemia in patients with nonmyeloid malignancies where anemia is due to the effect of concomitantly administered chemotherapy.Important Product Safety InformationAranesp® is contraindicated in patien...

Agennix

Agennix is a privately held biotechnology company whose lead molecule, Talactoferrin Alfa (talactoferrin; TLF), is an immunomodulatory protein. Agennix is currently preparing to initiate Phase III development of oral talactoferrin for cancer, and topical talactoferrin gel for wound healing.Liquid talactoferrin is an oral anti-cancer drug that has shown activity both as monotherapy and in combinati...


More From BioPortfolio on "Combination Chemotherapy in Treating Patients With Advanced Cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks